Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $31.96 Analyst target: $51.92 Upside: 62.45%
IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected patient populations using molecular diagnostics. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.